Jon Vincelette Selected Research

Jon Vincelette Research Topics

Disease

4	Vascular Remodeling 09/2009 - 04/2005
4	Atherosclerosis 09/2009 - 05/2005
4	Hemorrhage 05/2007 - 11/2004
3	Mucopolysaccharidosis III (Sanfilippo Syndrome) 12/2022 - 10/2014
3	Abdominal Aortic Aneurysm 09/2009 - 05/2005
3	Thrombosis (Thrombus) 05/2007 - 11/2004
2	Mucopolysaccharidoses 12/2022 - 09/2017
2	Neuraminidase 1 deficiency 11/2020 - 01/2020
2	GM1 Gangliosidosis (Gangliosidosis GM1) 01/2020 - 01/2020
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020 - 01/2020
2	Obesity 03/2011 - 02/2011
2	Hypertension (High Blood Pressure) 03/2011 - 02/2011
2	Hyperplasia 03/2008 - 03/2006
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Mucolipidoses (Sialidosis) 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Insulin Resistance 02/2011
1	Dyslipidemias (Dyslipidemia) 09/2009
1	Myocardial Infarction 01/2008
1	Ischemic Stroke 01/2008
1	Myocarditis (Carditis) 07/2007
1	Neointima 02/2007
1	Rheumatoid Arthritis 01/2007
1	Experimental Arthritis 01/2007
1	Disseminated Intravascular Coagulation 09/2006
1	Inflammation (Inflammations) 08/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2006
1	Hypercholesterolemia 03/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2005
1	Ventricular Dysfunction 04/2005
1	Cardiomegaly (Heart Hypertrophy) 04/2005
1	Hypertrophy 04/2005
1	Fibrosis (Cirrhosis) 04/2005
1	Pulmonary Embolism 11/2004

Drug/Important Bio-Agent (IBA)

8	Angiotensin IIIBA 03/2011 - 04/2005
4	ApolipoproteinsIBA 09/2009 - 04/2005
3	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2020 - 10/2014
3	EnzymesIBA 01/2020 - 10/2014
3	Epoxide HydrolasesIBA 03/2011 - 09/2009
3	rho-Associated KinasesIBA 11/2005 - 04/2005
2	GalactosidasesIBA 01/2020 - 01/2020
2	Heparitin Sulfate (Heparan Sulfate)IBA 09/2017 - 10/2014
2	Acetylglucosaminidase (NAGase)IBA 09/2017 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 11/2004
2	1- (1- acetyl- piperidine- 4- yl)- 3- adamantan- 1- yl- ureaIBA 03/2011 - 02/2011
2	Apolipoproteins E (ApoE)IBA 03/2008 - 07/2006
2	Interferon-betaIBA 03/2008 - 07/2007
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2008 - 05/2007
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2007 - 11/2004
2	fasudil (AT 877)IBA 05/2005 - 04/2005
1	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 12/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	BMN 250IBA 01/2020
1	5'-deoxy-5'-phosphonomethyladenosine phosphateIBA 01/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2020
1	NetrinsIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Netrin-1IBA 01/2016
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2011
1	1- (1- nicotinoylpiperidin- 4- yl)- 3- (4- (trifluoromethoxy)phenyl)ureaIBA 03/2011
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 02/2011
1	Antiviral Agents (Antivirals)IBA 07/2007
1	TransferasesIBA 07/2007
1	HypoxanthineIBA 07/2007
1	Messenger RNA (mRNA)IBA 07/2007
1	GuanineIBA 07/2007
1	4- (((4- (1- carboxy- 1- methylethoxy)- 7- methylquinolin- 2- yl)carbonyl)amino)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA 05/2007
1	4- ((4- (1- (ethoxycarbonyl)- 1- methylethoxy)- 7- methyl- 2- quinolyl)carbamoyl)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA 05/2007
1	Clopidogrel (Plavix)FDA Link 05/2007
1	Adenosine Diphosphate (ADP)IBA 05/2007
1	Purinergic P2Y Receptor AntagonistsIBA 05/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2007
1	Therapeutic UsesIBA 01/2007
1	BatroxobinIBA 01/2007
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2007
1	Thromboplastin (Tissue Factor)IBA 09/2006
1	Indicators and Reagents (Reagents)IBA 09/2006
1	Dacarbazine (DIC)FDA LinkGeneric 09/2006
1	Dobutamine FDA LinkGeneric 07/2006
1	HDL CholesterolIBA 03/2006
1	hydroxyfasudilIBA 11/2005
1	Vasopressins (Vasopressin)IBA 11/2005
1	GTP Phosphohydrolases (GTPases)IBA 04/2005
1	Atrial Natriuretic Factor (ANF)IBA 04/2005
1	Collagen Type III (Type III Collagen)IBA 04/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2004
1	P-SelectinIBA 11/2004

Therapy/Procedure

5	Enzyme Replacement Therapy 11/2020 - 10/2014
4	Ligation 09/2009 - 03/2006
1	Therapeutics 01/2020
1	Oral Administration 05/2007
1	Lasers (Laser) 01/2007
1	Intravenous Injections 09/2006